Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
80
WGS Quote, Financials, Valuation and Earnings
Last price:
$96.85
Seasonality move
:
71.65%
Day range:
$86.51 - $98.87
52-week range:
$2.80 - $89.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.86x
P/B ratio:
12.04x
Volume:
1.2M
Avg. volume:
560.9K
1-year change:
3428.73%
Market cap:
$2.5B
Revenue:
$202.6M
EPS (TTM):
-$3.11
Earnings Data
Next earnings date for WGS
Feb 20
2025
Most recent earnings per share
-$0.31
Missed by $0.10
(Oct 29/2024)
Consensus Estimate
-$0.22
(Oct 29/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
WGS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | $77.8M | -- | -- | $0.06 | -- |
| 02/20/2025 | Q4 | $80.2M | -- | -- | $0.11 | -- |
| 10/29/2024 | Q3 | $65M | $76.9M | -$0.31 | -$0.22 | -$0.10 |
| 07/30/2024 | Q2 | $59.3M | $70.5M | -$1.10 | -$0.30 | -$0.80 |
| 04/29/2024 | Q1 | $49.5M | $62.4M | -$0.78 | -$0.67 | -$0.11 |
| 02/20/2024 | Q4 | $57.6M | $57.4M | -$0.92 | -$0.65 | -$0.27 |
| 10/30/2023 | Q3 | -- | -- | -$1.64 | -$1.31 | -$0.33 |
| 08/08/2023 | Q2 | -- | -- | -$1.84 | -$1.31 | -$0.53 |
| 05/09/2023 | Q1 | -- | -- | -$3.04 | -$1.48 | -$1.56 |
| 03/14/2023 | Q4 | -- | -- | -$28.97 | -$5.28 | -$23.69 |
| 11/14/2022 | Q3 | -- | -- | -$6.72 | -$5.28 | -$1.44 |
| 06/30/2022 | Q2 | -- | -- | -$8.38 | -$5.61 | -$2.77 |
| 03/31/2022 | Q1 | -- | -- | -$10.38 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$5.61 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $5.28 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$6.34 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$26.35 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$17.27 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$7.78 | -- | -- |
GeneDx Holdings Earnings Questions
-
How Much did GeneDx Holdings Generate in Revenue Last Quarter?
GeneDx Holdings reported $76.9M worth of top line sales in its most recent quarter.
-
Did GeneDx Holdings Beat Earnings Last Quarter?
GeneDx Holdings announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.22 per share.
-
Is GeneDx Holdings Profitable?
GeneDx Holdings reported $47.8M that represents $1.77 per share over the last quarter.
-
What is the Analyst Consensus for GeneDx Holdings EPS Next Year?
GeneDx Holdings's earnings are forecast to decrease from -$7.23 per share to -$0.33 per share next year representing a decrease of -95.51%.
-
When is GeneDx Holdings's Earnings Date?
GeneDx Holdings's next earnings date is February 20, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
